Older adults who get Pfizer, Moderna jab 94% less likely to be hospitalised for Covid-19 – study

Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
0:00
play article
Subscribers can listen to this article
The injection Lebelwane received would have been either the ChAdOx1 nCoV-19 vaccine or a placebo of normal salt water. The vaccine’s name stems from ChAdOx1, the virus it is made of, a weakened and non-replicating version of a common cold virus. Picture: iStock/ Pcess609
The injection Lebelwane received would have been either the ChAdOx1 nCoV-19 vaccine or a placebo of normal salt water. The vaccine’s name stems from ChAdOx1, the virus it is made of, a weakened and non-replicating version of a common cold virus. Picture: iStock/ Pcess609

Seniors who were fully vaccinated with the Pfizer or Moderna Covid-19 vaccines were found to be highly protected against hospitalisation compared to unvaccinated adults of the same age, the latest data reveals.

This week, the Centers for Disease Control and Prevention (CDC) released the small study, which involved 417 patients aged 65 or older.

While the vaccine showed 94% effectiveness against Covid-29-related hospitalisation, this dropped to 64% in participants who only received a single dose less than two weeks earlier.

There’s more to this story
Subscribe to News24 and get access to our exclusive journalism and features today.
Subscribe
Already a subscriber? Sign in